Global Pharmaceutical Companies Move Toward Subcutaneous Injection Formulations for Cancer Immunotherapy

The post Global Pharmaceutical Companies Move Toward Subcutaneous Injection Formulations for Cancer Immunotherapy appeared first on News Directory 3.
Picture of an intravenous injection. /Select DB The pace of conversion of global pharmaceutical companies to subcutaneous (SC) injection formulations for cancer immunotherapy is accelerating. The current intravenous (IV) method of administration into a blood vessel (vein) took a long time to administer, placing a great burden on patients. As an alternative to solve the […]